Prenatal Carrier Screen (CF, Fragile X, SMA)
Use
This prenatal carrier screening panel assesses parental carrier status for three inherited conditions—cystic fibrosis (CF), Fragile X syndrome, and spinal muscular atrophy (SMA)—to help estimate reproductive risk in a prenatal or preconception setting. It includes CF screening via an expanded CFvantage® panel, X‑linked Fragile X testing (XSense® with reflex to methylation analysis), and SMA carrier detection including silent carrier (2+0) risk variant analysis.
Special Instructions
Not provided.
Limitations
Not provided.
Methodology
PCR-based (PCR)
Biomarkers
Result Turnaround Time
0 days
Related Documents
For more information, please review the documents below
Specimen
Whole Blood
Volume
4 mL (4 mL minimum)
Minimum Volume
Not provided
Container
EDTA (lavender‑top) tube
Collection Instructions
Normal phlebotomy procedure.
Storage Instructions
Store and ship room temperature immediately. Do not freeze.
Other tests from different labs that may be relevant